Altropane I-123 Uses, Dosage, Side Effects and more

Altropane I-123 is under investigation in clinical trial NCT01950468 (A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes).

Trade Name Altropane I-123
Generic Altropane I-123
Type
Formula C18H21FINO2
Weight Average: 425.275
Monoisotopic: 425.061230027
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share